Introduction: Previous case-control studies have suggested that the -1562C/T and R279Q polymorphisms of the matrix metalloproteinase 9 gene (MMP9) are associated with coronary heart disease (CHD). However, other studies do not confirm these relationships. The objective is to assess these relationships using meta-analysis. Methods: Databases, including PubMed and ScienceDirect, were searched to access the genetic association studies. Then data were extracted. Pooled odds ratio (OR) and 95% confidence interval (Cl) were calculated. Moreover, subgroup and sensitive analysis were performed. Results:The meta-analysis of the -1562C/T polymorphism included 12 studies with 8,336 cases and 3,984 controls. The -1562T allele was significantly associated with CHD (OR 1.25,95% CI 1.08-1.45, p = 0.004). There was heterogeneity among the 12 studies (I-2 = 61%, p = 0.003). The overall results were consistent and were not changed substantially by the removal of any data set. The meta-analysis of the R279Q polymorphism, including 6 studies with 6,983 cases and 3,282 controls, showed that the R279Q polymorphism was not associated with CHD (p = 0.16). Conclusions: The synthesis of available evidence supports the fact that the MMP9-1562C/T polymorphism is a risk factor for CHD. Copyright (C) 2013 S. Karger AG, Basel
[1]Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Diabet Res Inst, Shanghai Key Lab Tradit Chinese Clin Med,Dept End, Shanghai 201203, Peoples R China.
[2]Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.
(8.0+极速模式)